← Back to headlines
NeuroOne Targets $10.5M Revenue in 2026 with Brain and Pain Therapy Advancements
NeuroOne aims for at least $10.5 million in revenue in 2026 as it continues to develop its brain and pain therapy platforms.
17 Feb, 15:25 — 17 Feb, 15:25
ℹOnly 1 source covers this story
